GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
MLGRX
Price
$6.83
Change
-$0.41 (-5.66%)
Updated
Apr 3 closing price
Net Assets
12.37B
Ad is loading...

GFACX vs MLGRX

Header iconGFACX vs MLGRX Comparison
Open Charts GFACX vs MLGRXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
NYLI Winslow Large Cap Growth Class R3
Price$6.83
Change-$0.41 (-5.66%)
VolumeN/A
Net Assets12.37B
GFACX vs MLGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. MLGRX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and MLGRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. MLGRX (12.4B). GFACX (0.00) and MLGRX (0.00) have matching dividends . GFACX was incepted earlier than MLGRX: GFACX (24 years) vs MLGRX (19 years). GFACX (1.36) and MLGRX (1.30) have similar cost to investors . MLGRX is a more actively managed with annual turnover of: 70.00 vs. GFACX (25.00). MLGRX has a lower initial minimum investment than GFACX: MLGRX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. MLGRX (-15.81). GFACX return over 5 years is better than : 59.73 vs. MLGRX (3.28).
GFACXMLGRXGFACX / MLGRX
Total Expense Ratio1.361.29105%
Annual Report Gross Expense Ratio1.361.30105%
Fund Existence24 years19 years-
Gain YTD-5.003-6.70175%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets280B12.4B2,258%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.75-15.8111%
Returns for 3 years0.63-21.22-3%
Returns for 5 years59.733.281,821%
Returns for 10 years44.46-28.25-157%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences